Acer Therapeutics Inc (NASDAQ:ACER)

2.09
Delayed Data
As of Aug 16
 +0.14 / +7.18%
Today’s Change
1.87
Today|||52-Week Range
34.10
-89.61%
Year-to-Date

Today’s Trading

Previous close1.95
Today’s open1.99
Day’s range1.87 - 2.19
Volume481,895
Average volume (3 months)252,219
Market cap$21.1M
Data as of 4:00pm ET, 08/16/2019

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)-12.78%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
CLRBCellectar Bioscience...+0.06+2.83%
VICLVical Inc+0.07+8.75%
AYTUAytu BioScience Inc0.000.00%
EPIXESSA Pharma Inc+0.05+3.28%
Data as of 3:59pm ET, 08/16/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$0.00
Annual profit (last year)-$21.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Christopher Schelling
COO, CFO &
Principal Accounting Officer
Harry S. Palmin
Corporate headquarters
Newton, Massachusetts

Forecasts